Annual CFF
$281.34 M
+$149.80 M+113.88%
31 December 2023
Summary:
Evolent Health annual cash flow from financing activities is currently $281.34 million, with the most recent change of +$149.80 million (+113.88%) on 31 December 2023. During the last 3 years, it has risen by +$310.89 million (+1052.15%). EVH annual CFF is now at all-time high.EVH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$9.01 M
+$94.37 M+91.29%
30 September 2024
Summary:
Evolent Health quarterly cash flow from financing activities is currently -$9.01 million, with the most recent change of +$94.37 million (+91.29%) on 30 September 2024. Over the past year, it has increased by +$75.34 million (+89.32%). EVH quarterly CFF is now -102.37% below its all-time high of $379.73 million, reached on 31 March 2023.EVH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$181.86 M
+$28.36 M+13.49%
30 September 2024
Summary:
Evolent Health TTM cash flow from financing activities is currently -$181.86 million, with the most recent change of +$28.36 million (+13.49%) on 30 September 2024. Over the past year, it has dropped by -$463.20 million (-164.64%). EVH TTM CFF is now -132.17% below its all-time high of $565.29 million, reached on 30 June 2023.EVH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVH Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +89.3% | -164.6% |
| 3 y3 years | +1052.2% | -114.8% | -515.5% |
| 5 y5 years | +891.5% | +19.9% | -411.6% |
EVH Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1052.2% | -102.4% | +91.3% | -132.2% | +13.5% |
| 5 y | 5 years | at high | +891.5% | -102.4% | +91.3% | -132.2% | +13.5% |
| alltime | all time | at high | +891.5% | -102.4% | +91.8% | -132.2% | +13.5% |
Evolent Health Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.01 M(-91.3%) | -$181.86 M(-13.5%) |
| June 2024 | - | -$103.38 M(-794.7%) | -$210.22 M(+151.7%) |
| Mar 2024 | - | $14.88 M(-117.6%) | -$83.51 M(-129.7%) |
| Dec 2023 | $281.34 M(+113.9%) | -$84.35 M(+125.7%) | $281.34 M(-20.7%) |
| Sept 2023 | - | -$37.37 M(-260.2%) | $354.84 M(-37.2%) |
| June 2023 | - | $23.33 M(-93.9%) | $565.29 M(+0.5%) |
| Mar 2023 | - | $379.73 M(-3598.5%) | $562.65 M(+327.7%) |
| Dec 2022 | $131.54 M(-545.2%) | -$10.85 M(-106.3%) | $131.54 M(-35.3%) |
| Sept 2022 | - | $173.08 M(+736.5%) | $203.29 M(+558.9%) |
| June 2022 | - | $20.69 M(-140.3%) | $30.85 M(-221.8%) |
| Mar 2022 | - | -$51.38 M(-184.4%) | -$25.34 M(-14.2%) |
| Dec 2021 | -$29.55 M(+149.1%) | $60.90 M(+9400.5%) | -$29.55 M(-74.2%) |
| Sept 2021 | - | $641.00 K(-101.8%) | -$114.36 M(-11.3%) |
| June 2021 | - | -$35.50 M(-36.1%) | -$128.86 M(+28.8%) |
| Mar 2021 | - | -$55.58 M(+132.4%) | -$100.02 M(+743.2%) |
| Dec 2020 | -$11.86 M(-66.6%) | -$23.92 M(+72.6%) | -$11.86 M(-1568.1%) |
| Sept 2020 | - | -$13.86 M(+107.9%) | $808.00 K(-99.3%) |
| June 2020 | - | -$6.66 M(-120.5%) | $111.44 M(+4.4%) |
| Mar 2020 | - | $32.57 M(-389.6%) | $106.69 M(-400.2%) |
| Dec 2019 | -$35.55 M | -$11.25 M(-111.6%) | -$35.55 M(-113.8%) |
| Sept 2019 | - | $96.77 M(-948.4%) | $257.66 M(+64.5%) |
| June 2019 | - | -$11.41 M(-89.6%) | $156.62 M(-15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$109.67 M(-138.9%) | $185.97 M(-32.1%) |
| Dec 2018 | $274.02 M(+65.5%) | $281.96 M(-6703.3%) | $274.02 M(+1900.2%) |
| Sept 2018 | - | -$4.27 M(-123.8%) | $13.70 M(-92.5%) |
| June 2018 | - | $17.94 M(-183.0%) | $181.50 M(+19.0%) |
| Mar 2018 | - | -$21.61 M(-199.9%) | $152.58 M(-7.8%) |
| Dec 2017 | $165.56 M(+10.2%) | $21.64 M(-86.8%) | $165.56 M(-43.5%) |
| Sept 2017 | - | $163.53 M(-1588.6%) | $293.23 M(+124.2%) |
| June 2017 | - | -$10.99 M(+27.4%) | $130.78 M(-7.6%) |
| Mar 2017 | - | -$8.63 M(-105.8%) | $141.53 M(-5.8%) |
| Dec 2016 | $150.19 M(-29.9%) | $149.31 M(>+9900.0%) | $150.19 M(+2461.6%) |
| Sept 2016 | - | $1.08 M(-572.9%) | $5.86 M(+21.3%) |
| June 2016 | - | -$229.00 K(-1016.0%) | $4.83 M(-97.7%) |
| Mar 2016 | - | $25.00 K(-99.5%) | $214.19 M(+0.0%) |
| Dec 2015 | $214.16 M(>+9900.0%) | $4.98 M(+9129.6%) | $214.16 M(+2.4%) |
| Sept 2015 | - | $54.00 K(-100.0%) | $209.18 M(+0.0%) |
| June 2015 | - | $209.13 M(>+9900.0%) | $209.13 M(<-9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | -$961.00 K(<-9900.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(-100.0%) | $0.00(0.0%) |
| June 2014 | - | -$961.00 K(-200.0%) | $0.00(-100.0%) |
| Mar 2014 | - | $961.00 K | $961.00 K |
| Dec 2013 | $34.29 M | - | - |
FAQ
- What is Evolent Health annual cash flow from financing activities?
- What is the all time high annual CFF for Evolent Health?
- What is Evolent Health quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Evolent Health?
- What is Evolent Health quarterly CFF year-on-year change?
- What is Evolent Health TTM cash flow from financing activities?
- What is the all time high TTM CFF for Evolent Health?
- What is Evolent Health TTM CFF year-on-year change?
What is Evolent Health annual cash flow from financing activities?
The current annual CFF of EVH is $281.34 M
What is the all time high annual CFF for Evolent Health?
Evolent Health all-time high annual cash flow from financing activities is $281.34 M
What is Evolent Health quarterly cash flow from financing activities?
The current quarterly CFF of EVH is -$9.01 M
What is the all time high quarterly CFF for Evolent Health?
Evolent Health all-time high quarterly cash flow from financing activities is $379.73 M
What is Evolent Health quarterly CFF year-on-year change?
Over the past year, EVH quarterly cash flow from financing activities has changed by +$75.34 M (+89.32%)
What is Evolent Health TTM cash flow from financing activities?
The current TTM CFF of EVH is -$181.86 M
What is the all time high TTM CFF for Evolent Health?
Evolent Health all-time high TTM cash flow from financing activities is $565.29 M
What is Evolent Health TTM CFF year-on-year change?
Over the past year, EVH TTM cash flow from financing activities has changed by -$463.20 M (-164.64%)